KR7085660009
KR7085660009
CHA Biotech
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 1.268.253.668.580 | 1.045.049.021.120 | 21.4% |
| Cost of Revenue | 904.502.768.220 | 769.792.709.880 | 17.5% |
| Gross Profit | 363.750.900.360 | 275.256.311.240 | 32.1% |
| 412.193.397.970 | 334.940.447.570 | 23.1% | |
| Operating Income | -48.442.497.610 | -59.684.136.330 | 18.8% |
| Pretax Income | -143.262.854.280 | -2.913.705.320 | 4816.9% |
| Net Income Common Stockholders | -109.876.117.780 | -4.763.612.430 | 2206.6% |
| -- | -- | -- | |
| -- | -- | -- |